| Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers JX Caushi, J Zhang, Z Ji, A Vaghasia, B Zhang, EHC Hsiue, BJ Mog, ... Nature 596 (7870), 126-132, 2021 | 268 | 2021 |
| Targeting a neoantigen derived from a common TP53 mutation EHC Hsiue, KM Wright, J Douglass, MS Hwang, BJ Mog, AH Pearlman, ... Science 371 (6533), eabc8697, 2021 | 219 | 2021 |
| Bispecific antibodies targeting mutant RAS neoantigens J Douglass, EHC Hsiue, BJ Mog, MS Hwang, SR DiNapoli, AH Pearlman, ... Science Immunology 6 (57), eabd5515, 2021 | 112 | 2021 |
| Targeting public neoantigens for cancer immunotherapy AH Pearlman, MS Hwang, MF Konig, EHC Hsiue, J Douglass, ... Nature cancer 2 (5), 487-497, 2021 | 89 | 2021 |
| Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses AG Dykema, B Zhang, BA Woldemeskel, CC Garliss, LS Cheung, ... The Journal of clinical investigation 131 (10), 2021 | 76 | 2021 |
| Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes SY Ruan, YW Kuo, CT Huang, HC Hsiue, PR Hsueh International journal of antimicrobial agents 35 (1), 85-88, 2010 | 69 | 2010 |
| Targeting loss of heterozygosity for cancer-specific immunotherapy MS Hwang, BJ Mog, J Douglass, AH Pearlman, EHC Hsiue, S Paul, ... Proceedings of the National Academy of Sciences 118 (12), e2022410118, 2021 | 58 | 2021 |
| Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes JA Ligon, W Choi, G Cojocaru, W Fu, EHC Hsiue, TF Oke, N Siegel, ... Journal for immunotherapy of cancer 9 (5), 2021 | 56 | 2021 |
| Direct detection and quantification of neoantigens Q Wang, J Douglass, MS Hwang, EHC Hsiue, BJ Mog, M Zhang, ... Cancer immunology research 7 (11), 1748-1754, 2019 | 44 | 2019 |
| Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization HC Hsiue, YT Huang, YL Kuo, CH Liao, TC Chang, PR Hsueh Clinical Microbiology and Infection 16 (5), 493-500, 2010 | 44 | 2010 |
| TCR β chain–directed bispecific antibodies for the treatment of T cell cancers S Paul, AH Pearlman, J Douglass, BJ Mog, EHC Hsiue, MS Hwang, ... Science translational medicine 13 (584), eabd3595, 2021 | 35 | 2021 |
| Subcutaneous infection caused by Corynespora cassiicola, a plant pathogen HK Huang, CE Liu, JH Liou, HC Hsiue, CH Hsiao, PR Hsueh Journal of Infection 60 (2), 188-190, 2010 | 32 | 2010 |
| Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000–2008 HC Hsiue, SY Ruan, YL Kuo, YT Huang, PR Hsueh Clinical microbiology and infection 16 (8), 1204-1206, 2010 | 26 | 2010 |
| National policies fostering hospice care increased hospice utilization and reduced the invasiveness of End‐of‐Life care for cancer patients YY Shao, EHC Hsiue, CH Hsu, CA Yao, HM Chen, MS Lai, AL Cheng The Oncologist 22 (7), 843-849, 2017 | 24 | 2017 |
| Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens MS Hwang, MS Miller, P Thirawatananond, J Douglass, KM Wright, ... Nature communications 12 (1), 5271, 2021 | 22 | 2021 |
| Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients TH Wu, EHC Hsiue, JH Lee, CC Lin, WY Liao, CC Ho, JY Shih, CJ Yu, ... Clinical lung cancer 19 (3), e361-e372, 2018 | 21 | 2018 |
| Safety of gefitinib in non-small cell lung cancer treatment EHC Hsiue, JH Lee, CC Lin, JCH Yang Expert opinion on drug safety 15 (7), 993-1000, 2016 | 21 | 2016 |
| Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009 HC Hsiue, TH Wu, TC Chang, YC Hsiue, YT Huang, PI Lee, PR Hsueh European journal of clinical microbiology & infectious diseases 31, 1319-1326, 2012 | 18 | 2012 |
| Opportunities of circulating tumor DNA in lung cancer TH Wu, EHC Hsiue, JCH Yang Cancer Treatment Reviews 78, 31-41, 2019 | 17 | 2019 |
| Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer EHC Hsiue, JH Lee, CC Lin, JCH Yang Expert Review of Molecular Diagnostics 16 (12), 1251-1257, 2016 | 17 | 2016 |
